• 09 October, 2025

Lupin receives FDA nod for blood cells disorder drug

Pharma major Lupin announced that it has received approval for its Dec...

November 15, 2018 | Thursday | News
Aurobindo Pharma to acquire Australian firm's product

Aurobindo Pharma has said it's wholly-owned subsidiary has entered int...

November 14, 2018 | Wednesday | News
Suven secures product patents in Australia, Hong Kong

Suven Life Sciences Ltd (Suven) recently announced that the grant of o...

November 14, 2018 | Wednesday | News
Lupin launches generic solution of pneumonia in US

Pharma major Lupin has announced the launch of Atovaquone Oral Suspens...

November 13, 2018 | Tuesday | News
InvaGen announces acquisition agreement with Avenue Therapeutics

InvaGen Pharmaceuticals Inc., a subsidiary of the leading global pharm...

November 13, 2018 | Tuesday | News
Cipla gets USFDA nod for pain relief gel of osteoarthritis

Drug major Cipla has received final approval from the United States Fo...

November 12, 2018 | Monday | News
Biocon's Bengaluru plant completes USFDA inspection without any observations

Biotechnology major Biocon said that the US health regulator has compl...

November 12, 2018 | Monday | News
Lupin gets EIR from USFDA for Nagpur facility

Pharma major Lupin has announced the receipt of the Establishment Insp...

November 12, 2018 | Monday | News
Strides enters into partnership with SUDA Pharma for migraine drug

Strides Pharma Science Limited (Strides)  has announced  tha...

November 9, 2018 | Friday | News
AstraZeneca to sell rights of Alvesco, Omnaris, Zetonna

AstraZeneca has entered into an agreement with Covis Pharma B.V. (Covi...

November 7, 2018 | Wednesday | News
Lilly, NextCure to develop novel immuno-onco medicines

Eli Lilly and Company and NextCure, Inc. have announced a multi-year c...

November 6, 2018 | Tuesday | News
FDA completes successful inspection of DCA Bavla site

India-based Dishman Carbogen Amcis Limited (DCA), a global outsourcing...

November 6, 2018 | Tuesday | News
Lupin receives FDA approval for Doxercalciferol Injection

Pharma major Lupin has received approval for its Doxercalciferol Injec...

November 5, 2018 | Monday | News
Nephroplus acquires DaVita Care India

NephroPlus, India’s largest dialysis care network and a trailbla...

November 5, 2018 | Monday | News
Lupin recalls 6,752 bottles of Testosterone Topical solution from U.S.

The US arm of drug firm Lupin is recalling 6,752 bottles of Testostero...

November 5, 2018 | Monday | News
Aurobindo initiates to recall oncogenic hypertension drug

Aurobindo Pharma Limited has initiated voluntary recall of 22 batches ...

November 5, 2018 | Monday | News
Roche's new drugs will replace lost sales: Schwan

Roche Chief Executive Severin Schwan said new drugs the ...

November 5, 2018 | Monday | News
Zydus Cadila launches generic erectile dysfunction drug in US

Drug firm Zydus Cadila has said that it has launched generic Vardenafi...

November 2, 2018 | Friday | News

Trending Topics

Most Read

Survey Box

Do India's Pharma Reforms Target Global Credibility?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy